Mml Investors Services, LLC Bei Gene, Ltd. Transaction History

Mml Investors Services, LLC

$27.4 Billion
Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Mml Investors Services, LLC holds 4,434 shares of BGNE stock, worth $793,952. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,434

Previous 5,236 15.32%

Holding current value

$793,952

Previous $747,000 33.2%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	SELL	$143.93 - $224.51 $115,431 - $180,057	-802 Reduced 15.32%	4,434 $995,000
Q2 2024 Aug 14, 2024	SELL	$129.52 - $174.32 $259,558 - $349,337	-2,004 Reduced 27.68%	5,236 $747,000
Q1 2024 May 14, 2024	BUY	$141.8 - $181.47 $195,400 - $250,065	1,378 Added 23.51%	7,240 $1.13 Million
Q4 2023 Feb 14, 2024	BUY	$158.67 - $201.58 $143,913 - $182,833	907 Added 18.3%	5,862 $1.06 Million
Q3 2023 Nov 14, 2023	SELL	$179.87 - $225.13 $52,162 - $65,287	-290 Reduced 5.53%	4,955 $891,000
Q2 2023 Aug 14, 2023	BUY	$178.3 - $266.78 $9,628 - $14,406	54 Added 1.04%	5,245 $935,000
Q1 2023 May 12, 2023	BUY	$215.53 - $274.5 $156,474 - $199,287	726 Added 16.26%	5,191 $1.12 Million
Q4 2022 Feb 13, 2023	BUY	$125.51 - $229.3 $37,653 - $68,790	300 Added 7.2%	4,465 $982,000
Q3 2022 Nov 14, 2022	BUY	$131.8 - $202.24 $30,973 - $47,526	235 Added 5.98%	4,165 $562,000
Q2 2022 Aug 12, 2022	BUY	$121.11 - $216.05 $3,269 - $5,833	27 Added 0.69%	3,930 $636,000
Q1 2022 May 13, 2022	BUY	$146.52 - $269.56 $161,172 - $296,516	1,100 Added 39.24%	3,903 $736,000
Q4 2021 Feb 14, 2022	BUY	$248.56 - $389.34 $55,428 - $86,822	223 Added 8.64%	2,803 $759,000
Q3 2021 Nov 15, 2021	BUY	$249.6 - $403.14 $18,220 - $29,429	73 Added 2.91%	2,580 $937,000
Q2 2021 Aug 13, 2021	BUY	$292.75 - $367.01 $111,245 - $139,463	380 Added 17.87%	2,507 $860,000
Q1 2021 May 14, 2021	BUY	$260.64 - $382.12 $197,043 - $288,882	756 Added 55.14%	2,127 $740,000
Q4 2020 Feb 12, 2021	SELL	$221.31 - $316.61 $14,385 - $20,579	-65 Reduced 4.53%	1,371 $354,000
Q3 2020 Nov 13, 2020	BUY	$189.18 - $286.44 $271,662 - $411,327	1,436 New	1,436 $411,000

Others Institutions Holding BGNE

# of Institutions

252

Shares Held

45.3M

Call Options Held

292K

Put Options Held

119K

View Full List

About BeiGene, Ltd.

Ticker BGNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,700,000
Market Cap $18.6B
Description
BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...

More about BGNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Account

Mml Investors Services, LLC Bei Gene, Ltd. Transaction History